Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NGL FINE CHM vs BAFNA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NGL FINE CHM BAFNA PHARMA NGL FINE CHM/
BAFNA PHARMA
 
P/E (TTM) x 33.5 16.1 208.6% View Chart
P/BV x 5.8 2.5 234.4% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 NGL FINE CHM   BAFNA PHARMA
EQUITY SHARE DATA
    NGL FINE CHM
Mar-23
BAFNA PHARMA
Mar-23
NGL FINE CHM/
BAFNA PHARMA
5-Yr Chart
Click to enlarge
High Rs2,569141 1,822.0%   
Low Rs1,16179 1,479.2%   
Sales per share (Unadj.) Rs450.048.8 923.0%  
Earnings per share (Unadj.) Rs33.24.8 692.1%  
Cash flow per share (Unadj.) Rs51.47.0 729.9%  
Dividends per share (Unadj.) Rs1.750-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs360.131.0 1,159.9%  
Shares outstanding (eoy) m6.1823.66 26.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.12.3 184.1%   
Avg P/E ratio x56.222.9 245.5%  
P/CF ratio (eoy) x36.315.6 232.8%  
Price / Book Value ratio x5.23.5 146.5%  
Dividend payout %5.30-   
Avg Mkt Cap Rs m11,5232,596 443.8%   
No. of employees `000NANA-   
Total wages/salary Rs m369159 232.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,7811,154 241.1%  
Other income Rs m5533 169.0%   
Total revenues Rs m2,8361,186 239.1%   
Gross profit Rs m350157 222.4%  
Depreciation Rs m11353 211.7%   
Interest Rs m1820 90.0%   
Profit before tax Rs m274116 235.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m693 2,469.8%   
Profit after tax Rs m205113 180.8%  
Gross profit margin %12.613.6 92.3%  
Effective tax rate %25.12.4 1,047.3%   
Net profit margin %7.49.8 75.0%  
BALANCE SHEET DATA
Current assets Rs m1,627873 186.3%   
Current liabilities Rs m583465 125.4%   
Net working cap to sales %37.535.4 106.0%  
Current ratio x2.81.9 148.5%  
Inventory Days Days652 3,801.9%  
Debtors Days Days8651,302 66.4%  
Net fixed assets Rs m1,244423 294.3%   
Share capital Rs m31237 13.1%   
"Free" reserves Rs m2,195498 440.7%   
Net worth Rs m2,225735 303.0%   
Long term debt Rs m2184 24.6%   
Total assets Rs m2,8711,296 221.5%  
Interest coverage x15.96.7 237.6%   
Debt to equity ratio x00.1 8.1%  
Sales to assets ratio x1.00.9 108.8%   
Return on assets %7.810.3 75.4%  
Return on equity %9.215.4 59.7%  
Return on capital %13.016.7 78.0%  
Exports to sales %74.30-   
Imports to sales %9.97.9 126.4%   
Exports (fob) Rs m2,066NA-   
Imports (cif) Rs m27691 304.8%   
Fx inflow Rs m2,095885 236.6%   
Fx outflow Rs m30491 335.9%   
Net fx Rs m1,790794 225.3%   
CASH FLOW
From Operations Rs m35350 712.4%  
From Investments Rs m-270-75 360.6%  
From Financial Activity Rs m-11102 -10.6%  
Net Cashflow Rs m7276 94.1%  

Share Holding

Indian Promoters % 73.1 88.4 82.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.9 11.6 232.8%  
Shareholders   16,410 7,367 222.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NGL FINE CHM With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on NGL FINE CHM vs BAFNA PHARM.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

NGL FINE CHM vs BAFNA PHARM. Share Price Performance

Period NGL FINE CHM BAFNA PHARM. S&P BSE HEALTHCARE
1-Day -1.06% -1.28% 1.18%
1-Month 2.44% -11.90% -0.75%
1-Year 76.61% -4.38% 61.82%
3-Year CAGR 9.65% -19.10% 18.16%
5-Year CAGR 35.23% 47.52% 19.79%

* Compound Annual Growth Rate

Here are more details on the NGL FINE CHM share price and the BAFNA PHARM. share price.

Moving on to shareholding structures...

The promoters of NGL FINE CHM hold a 73.1% stake in the company. In case of BAFNA PHARM. the stake stands at 88.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NGL FINE CHM and the shareholding pattern of BAFNA PHARM..

Finally, a word on dividends...

In the most recent financial year, NGL FINE CHM paid a dividend of Rs 1.8 per share. This amounted to a Dividend Payout ratio of 5.3%.

BAFNA PHARM. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of NGL FINE CHM, and the dividend history of BAFNA PHARM..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.